Publication | Open Access

Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)

Tumor BiologyCell RegulationMedicineReceptor Tyrosine KinaseTsc2-deficient CellsCancer Cell BiologyTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingCancer Research